Novo Nordisk has continued to push forward in the new target weight loss drug field and recently expanded its partnership with Valo Health to leverage Valo's large human dataset and AI-driven computing power to accelerate the development of new therapies for obesity, type 2 diabetes, and cardiovascular diseases
Eur Thyroid J 8(1):1623 Bulotta S, Capriglione F, Celano M, Pecce V, Russo D, Maggisano V (2021) Phytochemicals in thyroid cancer: analysis of the preclinical studies
Todas las transacciones se realizan a travs de pasarelas de pago seguras con cifrado SSL.
Impact of V9302, a competitive antagonist of transmembrane glutamine flux on reversal of resistance in breast cancer cell lines
Arias-Santiago et al., Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma